SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Hospice and Palliative Medicine®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rousseau, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rousseau, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Pain
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The palliative use of high-dose corticosteroids in three terminally ill patients with pain

Paul Rousseau, MD

Geriatrics and Extended Care, VA Medical Center, Phoenix, Arizona, RTA Hospice and Palliative Care, Phoenix, Arizona, Arizona College of Osteopathic Medicine, Glendale, Arizona, Adult Development and Aging, Arizona State University, Tempe, Arizona

Corticosteroids are valuable pharmacological adjuncts utilized in the management of the diverse symptoms observed in terminally ill patients, including bone, neuropathic, and hepatic pain, asthenia and fatigue, and anorexia, and serve as an adjunct for the treatment of nausea and vomiting. If relief of suffering is the goal and mandate of palliative care, high-dose corticosteroids should be utilized in terminally ill patients for quickly reducing pain and improving quality of life for both patients and family members. In patients with a limited life expectancy of days to several weeks, long-term side effects will not occur and therefore should not preclude the continuous use of corticosteroids until the patient’s death. Three case studies are presented.

Key Words: corticosteroids • dexamethasone • methylprednisolone • pain control • prednisolone • prednisone • symptom management

American Journal of Hospice and Palliative Medicine®, Vol. 18, No. 5, 343-346 (2001)
DOI: 10.1177/104990910101800510


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
I. E. Haines and R. M. Stanley
Perspective on "Chemotherapy for Advanced Prostate Cancer: 25 Years Later": Is It a Mirage or an Oasis?
J. Clin. Oncol., August 20, 2008; 26(24): 4049 - 4050.
[Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
P. Rousseau
Sudden withdrawal of corticosteroids: A commentary
American Journal of Hospice and Palliative Medicine, May 1, 2004; 21(3): 169 - 171.
[PDF]



Advertisement